These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16822314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN, Bernstein DI.
    Virology; 1995 Oct 01; 212(2):481-9. PubMed ID: 7571418
    [Abstract] [Full Text] [Related]

  • 3. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA, Rosenthal KL.
    J Reprod Immunol; 2010 Dec 01; 87(1-2):39-44. PubMed ID: 20688399
    [Abstract] [Full Text] [Related]

  • 4. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.
    Cytometry B Clin Cytom; 2008 Jul 01; 74(4):211-20. PubMed ID: 18454493
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, Jackson DC, Cunningham AL.
    J Immunol; 2012 May 01; 188(9):4158-70. PubMed ID: 22467654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    Milligan GN, Bernstein DI, Bourne N.
    J Immunol; 1998 Jun 15; 160(12):6093-100. PubMed ID: 9637526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A, Musselli C, Chen H, Pappas J, Leclair K, Liu A, Chicz RM, Truneh A, Monks S, Levey DL, Srivastava PK.
    Vaccine; 2011 Nov 03; 29(47):8530-41. PubMed ID: 21767588
    [Abstract] [Full Text] [Related]

  • 11. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):178-87. PubMed ID: 18172269
    [Abstract] [Full Text] [Related]

  • 12. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038
    [Abstract] [Full Text] [Related]

  • 13. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
    Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, Macdonald KS, Ngugi E, Bwayo JJ, Moses S, Kovacs C, Loutfy M, Kaul R.
    J Infect Dis; 2008 May 15; 197(10):1394-401. PubMed ID: 18444797
    [Abstract] [Full Text] [Related]

  • 14. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells.
    Danke NA, Koelle DM, Kwok WW.
    Hum Immunol; 2005 Jul 15; 66(7):777-87. PubMed ID: 16112025
    [Abstract] [Full Text] [Related]

  • 15. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
    Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L.
    J Immunol; 2001 Mar 15; 166(6):4049-58. PubMed ID: 11238653
    [Abstract] [Full Text] [Related]

  • 16. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F, de Andrade HF, Fernandes ER, Tuon FF, Brasil RA, Pagliari C, Duarte MI.
    Br J Dermatol; 2008 Sep 15; 159(4):839-46. PubMed ID: 18644020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype.
    Khan N, Cobbold M, Keenan R, Moss PA.
    J Infect Dis; 2002 Apr 15; 185(8):1025-34. PubMed ID: 11930311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.